EY- GLP-1 70% , 60%
Tirzepatide Tirzepatide is a newer medication that works as a dual GIP/GLP-1 receptor agonist, targeting two hormones involved in appetite and blood sugar regulation
Despite this, many patients persevere because of the undeniable benefits these medications offer
For meaningful assessment of treatment response, standardized measurements should be employed, including limb circumference at defined anatomical points, validated pain scales, and quality-of-life instruments specific to lipedema or lymphatic conditions
These findingsoriginating from landmark trials such as EMPA-REG OUTCOME, LEADER, and SUSTAIN-6have led to substantial revisions in international guidelines from the European Society of Cardiology, American College of Cardiology, and American Heart Association, which now recommend the use of SGLT2i or GLP-1 RAs, often in conjunction with metformin
Schedule a Free Consultation SIGN UP ONLINE OR CALL 718-448-3800